Mental Health Clinics in Scottville, MI Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Memorial Medical Center Of West Michigan Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 300 W Broadway Ave, Scottville, MI 49454 Phone: 231-834-5995 |
News Archive
Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific
Carl Zeiss Meditec AG announces it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a US-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, California, has been manufacturing IOLs for more than two decades. The majority of shares in Aaren Scientific had previously been owned by a private investment company as well as other investors, including the CEO and co-founder of Aaren Scientific, Rick Aguilera, who along with the entire management team will stay on board after the transaction.
Equal-access health care system may help eliminate racial disparities among men with prostate cancer
Among men with prostate cancer who received care from the Veterans Affairs (VA) Health System, an equal-access health care system, African American men did not have more advanced disease at the time of diagnosis or die earlier than white men, unlike trends seen in the greater U.S. population of patients with prostate cancer.
Scientists reveal link between smaller hippocampal brain volume and marijuana use
How scientists study the effects of marijuana on the brain is changing. Until recently marijuana research largely excluded tobacco users from its participant pool, but scientists at the Center for BrainHealth at The University of Texas at Dallas have found reason to abandon this practice, uncovering significant differences in the brains of individuals who use both tobacco and marijuana and the brains of those who only use marijuana.
Bayer's regorafenib granted FDA Fast Track designation for treatment of GIST
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
› Verified 7 days ago